No medical procedure is zero-risk. This page is our complete, unfiltered account of what can go wrong with HA penile girth enhancement, how we prevent it, how we manage it if it occurs, and what you should watch for afterward.
Of all the soft-tissue augmentation options used anywhere in the human body, hyaluronic acid has the best combination of (a) a predictable, visible result, (b) a well-characterised complication profile, and (c) full reversibility using an injectable enzyme called hyaluronidase. No other filler class has all three. This is why HA dominates the global aesthetic market and why it is the only class of filler we use for penile girth enhancement.
This does not mean the procedure is risk-free. It means the risks are well-characterised, mostly manageable, and — critically — reversible.
These are expected in most procedures. They are part of normal recovery rather than complications.
Management: cold compresses for the first 24 hours, oral paracetamol (acetaminophen) as needed for discomfort, loose underwear, and no strenuous activity for 3 days. We provide a written protocol at discharge.
Filler distributes along the soft tissue plane, but tissue elasticity and scar patterns are not always perfectly symmetric. In approximately 6% of cases, a modest asymmetry is visible at follow-up. Management is a small supplementary injection at the less-treated side, at no additional cost within the first 30 days. We photograph and measure every procedure, so the baseline for the correction is objective.
"Migration" refers to a portion of filler shifting downward or proximally from the intended zone. This can be reversed with a localised injection of hyaluronidase, which dissolves the displaced HA. The tissue then returns to a state where the primary filler remains in the correct plane. Typically diagnosed at the 4-week review or earlier.
Small, firm, typically non-tender lumps — 2–5 mm in size — can develop in the first few weeks as filler settles unevenly or as the tissue responds at the edge of a deposit. The majority resolve spontaneously over 4–8 weeks. Persistent nodules are treated with localised hyaluronidase, which dissolves them rapidly.
Any procedure that breaks the skin carries an infection risk, however small. In penile HA work the published rate is around 1.5%. We mitigate it with sterile drapes, single-use cannulas, chlorhexidine preparation, and a requirement that patients notify us within 12 hours of any new redness, heat, discharge, or fever in the days following the procedure. Early infections are managed with oral antibiotics; no peer-reviewed case series has reported progression to surgical intervention when the infection was reported and treated promptly.
In rare cases, a faint change in skin tone can persist for several weeks at the entry site. This fades without intervention in the majority of cases. Persistent pigmentation — exceptionally rare — can be addressed with topical treatments or a short course of laser therapy if it does not resolve.
Intravascular injection of filler — that is, injection of product directly into a blood vessel rather than the surrounding soft tissue — is the most serious theoretical complication of any filler procedure. It can cause ischaemia of the tissue supplied by the occluded vessel. In the penile context this could theoretically result in localised tissue damage.
The blunt cannula technique is specifically designed to eliminate this risk. Unlike a sharp needle, a blunt cannula cannot penetrate an intact blood vessel under normal injection pressure — it pushes vessels aside rather than piercing them. In peer-reviewed case series using cannula technique for penile HA, no cases of vascular occlusion have been reported.
Management protocol, in the exceptionally unlikely event of suspected vascular compromise: immediate cessation of injection, massage to break up the filler, on-site injection of hyaluronidase (dissolves the HA directly, releasing any vascular obstruction), and urgent clinical review. Hyaluronidase is stocked on site, not ordered in.
Granuloma is a delayed inflammatory response to a foreign material. It is extraordinarily rare with HA filler (case reports at the level of the literature, not case series), and essentially always reversible with hyaluronidase. It is, by contrast, a well-recognised complication of permanent fillers (PMMA, silicone) — which is one of the core reasons we do not use them.
In peer-reviewed series using cannula technique and HA filler, no cases of permanent tissue damage have been reported. This is the single strongest argument for the cannula approach.
Medical history, medications, allergies, prior aesthetic treatments. Any contraindications are identified before you pay, before you travel, before the needle is drawn up.
Sterile drapes, skin preparation with chlorhexidine, single-use disposable cannula, single-use syringe, gloved operator. Nothing is reused.
The cannula technique eliminates the main pathway to vascular injury and substantially reduces bruising, trauma, and entry-site complications.
CE-marked Teosyal, batch-traceable. Every batch recorded in your patient file. No generic, no unbranded, no "premium HA" as a euphemism.
Every procedure performed by Prof. Dr. Sertkaya personally. No rotating operators, no aesthetician delegation, no "assistant performs, doctor supervises" arrangement.
The enzymatic reversal of HA filler is kept in stock, not ordered on demand. If it is ever needed, it is available in the same clinic, the same day.
The single most important safety feature of HA filler — and the reason it is the international clinical standard — is that it can be completely reversed with an injectable enzyme called hyaluronidase. Hyaluronidase breaks the cross-links in the HA gel, returning it to its component parts, which are then metabolised by the body. The tissue returns to baseline within 24–48 hours.
In our clinic, hyaluronidase is available on site and at no additional charge in any of the following scenarios:
Whether reversal is complete or partial depends on the clinical indication. Partial reversal can address a specific asymmetry without disturbing the rest of the result. Full reversal returns the tissue to baseline.
If a permanent filler produces an imperfect result, there are very few good options. Surgical excision of permanent filler material is invasive, carries its own complication profile, and may leave an outcome worse than the one being corrected. Reversibility is the safety net that HA filler gives you and that no permanent alternative can. Any clinic offering a "permanent" penile filler has removed the patient's most important safety option. We consider that unacceptable, full stop.
A subset of patients are not appropriate candidates for this procedure, and we will identify and discuss this at consultation. Contraindications include:
Most complications, when they occur, declare themselves in the first 7–14 days. Contact us immediately — via the 30-day WhatsApp aftercare channel — if you observe any of the following:
Every patient signs a written informed consent document before the procedure. The document lists all of the complications discussed on this page, in plain language, plus the clinic's commitments on reversal, follow-up, and cost. We encourage patients to take the document to their hotel, read it carefully, and return with any questions. The signed copy goes on your patient file; you keep an identical unsigned copy.
Good medicine is not the absence of risk. It is the honest discussion of risk, rigorous prevention, transparent management when complications occur, and a reliable reversal option when one is needed. We hold ourselves to this standard on every procedure. — Safety commitment, Fill in Istanbul
The free consultation is the right time to ask every safety question you can think of. We would rather spend an extra half hour answering than have you worry about any aspect of the procedure.